Prenetics Global Limited (NASDAQ:PRE - Get Free Report) was down 2.6% during mid-day trading on Monday . The stock traded as low as $5.10 and last traded at $5.25. Approximately 8,525 shares traded hands during mid-day trading, a decline of 50% from the average daily volume of 17,120 shares. The stock had previously closed at $5.39.
Prenetics Global Stock Performance
The company has a 50-day simple moving average of $4.46 and a two-hundred day simple moving average of $4.94. The firm has a market capitalization of $76.22 million, a P/E ratio of -1.57 and a beta of -0.26.
Hedge Funds Weigh In On Prenetics Global
A hedge fund recently raised its stake in Prenetics Global stock. Nomura Holdings Inc. raised its stake in shares of Prenetics Global Limited (NASDAQ:PRE - Free Report) by 3.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 333,528 shares of the company's stock after purchasing an additional 10,576 shares during the period. Nomura Holdings Inc. owned 2.73% of Prenetics Global worth $1,307,000 as of its most recent filing with the Securities & Exchange Commission. 25.01% of the stock is owned by institutional investors and hedge funds.
Prenetics Global Company Profile
(
Get Free Report)
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.
Featured Stories
Before you consider Prenetics Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prenetics Global wasn't on the list.
While Prenetics Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
